title: Anti-interleukin-17 therapy for degenerated and herniated human intervertebral disc tissues? Comment on the article by Shamji et al.
authors.forename: Haili
authors.initials: H
authors.lastname: Wang
authors.forename: Marcus
authors.initials: M
authors.lastname: Schiltenwolf
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D020381:Interleukin-17 / Q000037:antagonists & inhibitors / Q000276:immunology*; D007403:Intervertebral Disc / Q000276:immunology / Q000473:pathology; D055959:Intervertebral Disc Degeneration / Q000150:complications / Q000276:immunology / Q000473:pathology*; D007405:Intervertebral Disc Displacement / Q000150:complications / Q000276:immunology / Q000473:pathology*; D017116:Low Back Pain / Q000209:etiology / Q000276:immunology / Q000473:pathology*
chemical_list: D000911:Antibodies, Monoclonal; D020381:Interleukin-17